Most bought healthcare stocks in Q1 2026
Discover which Healthcare stocks institutional investors added to most aggressively over Q1 2026 versus the prior calendar quarter in our filings. Notable additions at the top of this list include PFIZER INC (PFE), MERCK & CO. INC. (MRK), VIATRIS INC (VTRS), MYRIAD GENETICS INC (MYGN). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Net share increases
Top symbols by net quarter-over-quarter share change (increases).
Most bought stocks
Net quarter-over-quarter share increases across all institutional filers.
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| PFE | PFIZER INC | 546,851,136 | $24.6B | 244 | 1278 | 1069 | 175 | 2891 |
| MRK | MERCK & CO. INC. | 171,510,048 | $45.7B | 317 | 1411 | 1528 | 127 | 3674 |
| VTRS | VIATRIS INC | 149,857,835 | $2.9B | 131 | 346 | 313 | 96 | 1000 |
| MYGN | MYRIAD GENETICS INC | 128,625,808 | -$6.8M | 32 | 75 | 66 | 49 | 200 |
| IPSC | CENTURY THERAPEUTICS INC | 113,742,557 | $286.6M | 31 | 16 | 10 | 7 | 70 |
| JNJ | JOHNSON & JOHNSON | 110,070,822 | $97.6B | 295 | 1684 | 2105 | 135 | 4546 |
| ABBV | ABBVIE INC | 104,352,992 | $10.7B | 196 | 1685 | 1641 | 187 | 3973 |
| ABT | ABBOTT LABORATORIES | 104,248,731 | -$9.0B | 174 | 1099 | 1396 | 306 | 3031 |
| BMY | BRISTOL-MYERS SQUIBB CO | 87,529,291 | $13.6B | 262 | 1038 | 857 | 152 | 2478 |
| BSX | BOSTON SCIENTIFIC CORP | 86,034,058 | -$31.6B | 189 | 659 | 627 | 277 | 1640 |
| ERAS | ERASCA INC | 77,432,487 | $3.3B | 96 | 76 | 39 | 24 | 222 |
| LXRX | LEXICON PHARMACEUTICALS INC | 74,499,287 | $218.0M | 31 | 39 | 28 | 15 | 134 |
| ELAN | ELANCO ANIMAL HEALTH INC | 71,468,273 | $1.9B | 97 | 192 | 151 | 55 | 509 |
| UNH | UNITEDHEALTH GROUP INC | 70,283,432 | -$15.8B | 187 | 1161 | 1360 | 396 | 2964 |
| ALXO | ALX ONCOLOGY HOLDINGS INC | 66,692,537 | $157.2M | 25 | 18 | 11 | 13 | 68 |
| OCGN | OCUGEN INC | 66,577,740 | $139.9M | 46 | 42 | 22 | 18 | 135 |
| CVS | CVS HEALTH CORP | 63,061,358 | -$3.3B | 154 | 716 | 734 | 199 | 1839 |
| GILD | GILEAD SCIENCES INC | 61,271,030 | $24.6B | 244 | 843 | 876 | 105 | 2280 |
| RXRX | RECURSION PHARMACEUTICALS-A | 57,889,703 | -$101.0M | 59 | 131 | 82 | 47 | 332 |
| CNC | CENTENE CORP | 57,516,617 | -$1.5B | 103 | 301 | 338 | 140 | 849 |
| CTMX | CYTOMX THERAPEUTICS INC | 57,361,077 | $332.9M | 77 | 58 | 27 | 20 | 177 |
| AVTR | AVANTOR INC | 56,479,487 | -$1.6B | 90 | 166 | 124 | 71 | 425 |
| SGMO | SANGAMO THERAPEUTICS INC | 56,466,488 | $5.6M | 27 | 30 | 16 | 16 | 110 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 56,135,083 | $860.3M | 72 | 114 | 74 | 42 | 296 |
| LLY | ELI LILLY & CO | 55,133,195 | -$45.4B | 234 | 1906 | 1669 | 232 | 4293 |
| GERN | GERON CORP | 48,555,216 | $101.3M | 37 | 90 | 53 | 40 | 252 |
| NEOG | NEOGEN CORP | 48,034,118 | $710.2M | 46 | 103 | 93 | 40 | 304 |
| OVID | OVID THERAPEUTICS INC | 46,264,846 | $139.7M | 29 | 33 | 20 | 10 | 102 |
| CATX | PERSPECTIVE THERAPEUTICS INC | 45,727,175 | $233.7M | 46 | 40 | 28 | 22 | 133 |
| DXCM | DEXCOM INC | 45,284,105 | $1.8B | 148 | 375 | 312 | 93 | 945 |
| MRNA | MODERNA INC | 43,793,417 | $7.7B | 145 | 231 | 195 | 86 | 708 |
| BKD | BROOKDALE SENIOR LIVING INC | 43,563,276 | $1.2B | 76 | 96 | 81 | 26 | 279 |
| RCEL | AVITA MEDICAL INC | 42,912,371 | $59.6M | 25 | 27 | 11 | 15 | 76 |
| WAT | WATERS CORP | 42,378,251 | $8.0B | 457 | 557 | 111 | 83 | 1155 |
| IBRX | IMMUNITYBIO INC | 40,721,373 | $1.0B | 145 | 134 | 60 | 32 | 380 |
| AMGN | AMGEN INC | 39,747,161 | $24.1B | 221 | 1181 | 1228 | 133 | 3079 |
| TALK | TALKSPACE INC | 39,597,756 | $318.5M | 67 | 50 | 42 | 29 | 177 |
| OGN | ORGANON & CO | 39,172,772 | $96.0M | 82 | 134 | 194 | 93 | 597 |
| SHC | SOTERA HEALTH CO | 38,850,959 | -$351.6M | 55 | 146 | 58 | 38 | 291 |
| ALMS | ALUMIS INC | 38,729,459 | $1.5B | 89 | 59 | 33 | 25 | 193 |
| CMPS | COMPASS PATHWAYS PLC | 37,810,631 | $133.3M | 53 | 68 | 25 | 27 | 188 |
| FOLD | AMICUS THERAPEUTICS INC | 37,679,803 | $444.9M | 53 | 107 | 88 | 81 | 293 |
| ESPR | ESPERION THERAPEUTICS INC | 37,424,392 | -$29.0M | 39 | 64 | 60 | 31 | 202 |
| ALHC | ALIGNMENT HEALTHCARE INC | 37,369,434 | $60.3M | 75 | 110 | 74 | 43 | 288 |
| VIR | VIR BIOTECHNOLOGY INC | 35,707,863 | $617.2M | 69 | 116 | 40 | 31 | 249 |
| SABS | SAB BIOTHERAPEUTICS INC | 34,696,832 | $135.9M | 34 | 24 | 6 | 6 | 75 |
| XRAY | DENTSPLY SIRONA INC | 34,169,458 | $424.0M | 75 | 138 | 111 | 50 | 374 |
| RLMD | RELMADA THERAPEUTICS INC | 33,970,520 | $339.1M | 37 | 27 | 24 | 10 | 103 |
| OPK | OPKO HEALTH INC | 33,615,887 | $20.0M | 42 | 58 | 58 | 24 | 227 |
| A | AGILENT TECHNOLOGIES INC | 32,793,071 | -$1.1B | 108 | 391 | 366 | 158 | 1048 |